Martin Edelman, MD
Fox Chase Cancer Center
Disclosure:
Employment
University of Maryland: Professor of Medicine: Employee
Compensation
Astra Zeneca: DSMB; Bristol Myers Squibb: Research Grants
Ownership
Andarix: Stock Options; Biomarker Strategies: Stock Options
Leadership
Alliance for Clinical Trials in Oncology: Board of Directors; ASCO: Chair, Education Committee (Lung Cancer); NRG: Co-chair, Lung Committee
Presentation(s):
-
Chemotherapeutic Management of Oligometastatic NSCLC
Tuesday, October 23
5:05 PM – 5:25 PM